In elderly lung cancer patients who were treated phytohemagglutinin (PHA), significant decreases were observed in the percentages of cells that were positive for CD3 or CD4, in the CD4/CD8 ratio and in lymphoblastogenesis (LB)40. Here, CD4 is linked to lung cancer.